sanofi

Page 3 of 6

For AstraZeneca’s COVID vaccine, less may be more—and that’s puzzling researchers
Health

For AstraZeneca’s COVID vaccine, less may be more—and that’s puzzling researchers

By Angelica LaVito, John Lauerman and Bloomberg
November 25, 2020
AstraZeneca-Oxford COVID vaccine on track for year end, CEO Pascal Soriot says
Health

AstraZeneca-Oxford COVID vaccine on track for year end, CEO Pascal Soriot says

By Suzi Ring, James Paton and Bloomberg
November 5, 2020
Leadership Next podcast with Sanofi CEO Paul Hudson.
Leadership

Sanofi CEO sees Big Pharma collaborating more even after a COVID vaccine is approved

By
October 27, 2020
Medical syringe is seen with 'covid-19' sign displayed on a screen in the background in this illustration photo taken in Poland on October 12, 2020.
Health

As COVID-19 numbers boom and markets tank, Europe’s leaders urge vaccine coordination

By
October 15, 2020
Investors send global stocks higher on vaccine hopes and stimulus goodies—but tech shares continue to lag
Newsletters

Investors send global stocks higher on vaccine hopes and stimulus goodies—but tech shares continue to lag

By
September 3, 2020
Sanofi, GlaxoSmithKline reach multi-billion dollar deal with U.S. for coronavirus vaccine
Newsletters

Sanofi, GlaxoSmithKline reach multi-billion dollar deal with U.S. for coronavirus vaccine

By
July 31, 2020
U.S. pledges $2.1 billion for up to 600 million doses of Sanofi, GlaxoSmithKline vaccine
Health

U.S. pledges $2.1 billion for up to 600 million doses of Sanofi, GlaxoSmithKline vaccine

By James Paton and Bloomberg
July 31, 2020
France’s Sanofi to sell stake in high-flying Regeneron to fund new drugs discoveries
International

France’s Sanofi to sell stake in high-flying Regeneron to fund new drugs discoveries

By James Paton, Riley Griffin and Bloomberg
May 26, 2020
British pharma giant AstraZeneca get $1 billion from the U.S. to make coronavirus vaccine
Health

British pharma giant AstraZeneca get $1 billion from the U.S. to make coronavirus vaccine

By John Lauerman and Bloomberg
May 21, 2020
Will COVID-19 change how Big Pharma does clinical trials?
Magazine

Will COVID-19 change how Big Pharma does clinical trials?

By
May 15, 2020
‘Unacceptable:’ A new France-U.S. spat erupts over Sanofi’s coronavirus vaccine plans
Health

‘Unacceptable:’ A new France-U.S. spat erupts over Sanofi’s coronavirus vaccine plans

By Phil Serafino and Bloomberg
May 14, 2020
Sanofi will combine its experimental coronavirus vaccine with GlaxoSmithKline Plc’s adjuvant technology, which may allow more doses of a shot to be produced.
Health

Sanofi and GlaxoSmithKline are teaming up to develop a coronavirus vaccine

By James Paton, Suzi Ring and Bloomberg
April 14, 2020
Paul Hudson, chief executive officer of Sanofi, gestures as he speaks during a panel session on the sidelines of the China International Import Expo (CIIE) in Shanghai, China, on Tuesday, Nov. 5, 2019. The CIIE -- now in its second year -- is designed to showcase the countrys desire to shift its economy toward consumption by buying more foreign goods. Photographer: Qilai Shen/Bloomberg via Getty Images
Newsletters

Big pharma’s big chance

By Katherine Dunn and Alan Murray
April 3, 2020
Sanofi CEO Paul Hudson
Newsletters

Coronavirus interruption of drug supply chain pushes Sanofi to open a firm in France

By
February 24, 2020
2nd China International Import Expo (CIIE) - Day 2
Health

Sanofi is set to launch a new European drug manufacturing firm

By
February 24, 2020

Most Popular